UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported) October 29, 2009

 

AMPHENOL CORPORATION

(Exact name of registrant as specified in its charter)

 

Delaware
(State or other jurisdiction
of incorporation)

 

1-10879

(Commission File Number)

 

22-2785165

(IRS Employer
Identification No.)

 

358 Hall Avenue, Wallingford, Connecticut

 

06492

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code  (203) 265-8900

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


 

Item 8.01  Other Events

 

On October 29, 2009, Amphenol Corporation (“Amphenol”) issued a press release announcing the pricing of its offering of $600 million aggregate principal amount of senior notes due 2014 (the “Notes”).  The Notes will have an interest rate of 4.75% per annum and are being issued at a price equal to 99.813% of their face value.  A copy of Amphenol’s press release is attached hereto as Exhibit 99.1 and is incorporated by reference herein.

 

Item 9.01  Financial Statements and Exhibits.

 

Exhibit 99.1            Press Release dated October 29, 2009

 

2


 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

AMPHENOL CORPORATION

 

 

 

 

By:

/s/ Diana G. Reardon

 

 

Diana G. Reardon

 

 

Senior Vice President and Chief Financial Officer

 

 

Date:  October 29, 2009

 

3


 

EXHIBIT INDEX

 

Exhibit No.

 

Description

99.1

 

Press Release dated October 29, 2009

 

 

 

 

4